Edmonton, Canada
Future Fields, founded in 2018, is pioneering a novel approach to biomanufacturing through its unique EntoEngine™ platform. This groundbreaking system is the first of its kind globally to harness whole fruit flies for recombinant protein production, marking a significant advancement in synthetic biology.
Headquartered in Canada, the company operates at the intersection of multiple sectors, including Agriculture, Biotechnology, and Life Sciences. By integrating sustainability and innovation, Future Fields has distinguished itself as a leader in AgriTech.
Noteworthy recent backing includes a $15.10M Series A investment as of February 23, 2023, underlining strong confidence from investors such as AgFunder, Bee Partners, Builders VC, Climate Capital, Toyota Ventures, Amplify Capital, Siddhi Capital, Milad Alucozai, and Green Circle Foodtech Ventures.
Key accolades include being a Green-certified lab and an active participant in the United Nations Global Compact initiative, aligning with ethical and sustainable business practices.
